Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÈòÁã ³ú¿¡ ¹æ»ç¼±Á¶»ç¿Í Cis-diamminedichloroplatinum(II)ÀÇ È¿°ú : Ä¡·á ÈÄ 3°³¿ù°ú 6°³¿ù¿¡¼­ÀÇ Á¶Á÷ÇÐÀûºÐ¼® The Effect of Irradiation andCis-diamminedichloroplatinum(II) in the Rat Brain :Analysis of Histopathology at 3 and 6Months after Treatment

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 1998³â 16±Ç 2È£ p.125 ~ 138
ÀÌ°æÀÚ, Àå½ÂÈñ, ±¸Çý¼ö,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ°æÀÚ (  ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ Ä¡·á¹æ»ç¼±°ú

Àå½ÂÈñ (  ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ Ä¡·á¹æ»ç¼±°ú
±¸Çý¼ö (  ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ Çغκ´¸®Çаú

Abstract

¸ñ Àû : ÈòÁãÀÇ Àü³ú¿¡ ¹æ»ç¼±Á¶»ç ÈÄ cis-diamminedichloroplatinum(II)(cisplatin)À» º¹°­³» ÁÖÀÔÇÏ¿© cisplatinÀÌ ¹æ»ç¼±¿¡ ÀÇÇÑ Èı⠳ú¼Õ»ó(3°³¿ù, 6°³¿ù)¿¡ ¹ÌÄ¡´Â È¿°ú¸¦ ¾Ë±â À§ÇÏ¿© ÀÌ ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.

¹æ¹ý ¹× Àç·á : ÈòÁ㸦 ¹æ»ç¼±Á¶»ç±º, cisplatin±º, ¹æ»ç¼±Á¶»ç¿Í cisplatin º´¿ë±ºÀ¸·Î ºÐ·ùÇÏ¿´´Ù. ¹æ»ç¼±Á¶»ç±ºÀº ¼±Çü°¡¼Ó±â¸¦ »ç¿ëÇÏ¿© 20 Gy, 22.5 GyÀÇ x-ray¸¦ °¢°¢ ÈòÁãÀÇ Àü³ú¿¡ ´ÜÀÏÁ¶»çÇÏ¿´´Ù. Cisplatin±ºÀº 2, 4, 8mg/kgÀ» °¢°¢ º¹°­³»¿¡ 1ȸ ÁÖÀÔÇÏ¿´´Ù.
º´¿ë±ºÀº ¹æ»ç¼±Á¶»ç(20 Gy, 22.5 Gy) ÈÄ Áï½Ã cisplatin(2mg/kg)¸¦ º¹°­³»¿¡ 1ȸ ÁÖÀÔÇÏ¿´´Ù. °¢ ±º¿¡ µû¶ó Ä¡·á ÈÄ 3°³¿ù°ú 6°³¿ù¿¡ µ¿¹°À» Èñ»ý½ÃÅ°°í ³úÀÇ Á¶Á÷º´¸®ÇÐÀû °Ë»ç¸¦ ½ÃÇàÇÏ¿´´Ù.

°á °ú :ÇöÀúÇÏ°Ô ³ªÅ¸³µÀ¸¸ç ÇöÀúÇÑ Ç÷°üÁÖÀ§¿Í ¿¬¼ö¸·¿¡ ¼º»ó¼¼Æ÷ÀÇ Áõ½ÄÀº anti-GFAP Ç×ü°Ë»ç·Î È®ÀεǾú´Ù. ¹æ»ç¼±Á¶»ç¿¡ ÀÇÇÑ Ç÷°üº¯È­¿Í ¼º»ó¼¼Æ÷ÀÇ Áõ½ÄÀÌ cisplatin¿¡ ÀÇÇؼ­ Áõ°¡µÇÁö´Â ¾Ê¾Ò´Ù.

°á ·Ð : Cisplatin°ú ¹æ»ç¼±Á¶»ç¿¡ ÀÇÇÑ Èı⠳ú¼Õ»óÀÇ º¯È­·Î ±¹¼ÒÀû ±«»ç°¡ ¾ç±º¿¡¼­ µ¿½Ã¿¡ ³ªÅ¸³²À¸·Î¼­ ³ú¼Õ»óÀÇ Á¤µµ¸¦ ÃßÁ¤Çϴµ¥ ±«»ç°¡ ÁöÇ¥ÀÎÀÚ·Î ÀÌ¿ëµÉ ¼ö ÀÖ´Ù°í º»´Ù. CisplatinÀÌ ¹æ»ç¼±¿¡ ÀÇÇÑ Ç÷°üÀÇ º¯È­¿Í ¼º»ó¼¼Æ÷ÀÇ Áõ½Ä¿¡´Â ¿µÇâÀ» ¹ÌÄ¡Áö
¾Ê¾ÒÀ¸¹Ç·Î, ³ú¿¡¼­ cisplatin°ú ¹æ»ç¼±ÀÇ »óÈ£ÀÛ¿ëÀ» ÆľÇÇϱâ À§Çؼ­´Â ÇâÈÄ ´õ ¸¹Àº ½ÇÇèÀÌ ÇÊ¿äÇÏ´Ù.

Purpose : To evalute the late effect(3 and 6 months) of cis-diamminedichloroplatinum(II)(cisplatin) on the radiation brain damage when the cisplatin was intraperitoneally infused immediately after whole brain irradiation in the rats.

Materials and Methods : The histolopathological findings of the brain were examined in rat brains at 3 and 6 months after the treatment. The rats were irradiated(20 or 22.5 Gy, RT) or cisplatin was injected intraperitoneally(2, 4, or 8mg/kg, CT) and in combined treatment group, cisplatin(2mg/kg) was injected immediately after irradiation(20 or 22.5 Gy). Histopathological examination was done mostly in irradiation or cisplatin alone groups, because the rats in combined group died during experimental period except 2 rats.

Results : The rats treated with cisplatin showed marked epithelial vacuolation with perivascular edema and vascular dilatation in choroid plexus at 3 months as well as multifocal necrosis involving fimbria and cerebellar hemispheres at 3 and 6
months. The changes were more prominent in rats with 2mg/kg injection compared to rats with 8mg/kg injection.The rats with RT and combined CT and RT showed characteristic delayed irradiation effects such as focal coagulation necrosis and vascular changes,
which were more marked than previous reports. Prominent perivascular and leptomeningeal astrocytic proliferation was well documented by anti-GFAP antibody. Cisplatin treatment did not enhance the effect of radiation-induced changes of blood vessels and astrocytic proliferation.

Consluion : The focal necrosis was the most consistently noted finding in this study, it suggested the possibility to use this as an evaluation factor for combined effects of RT and cisplatin.

Å°¿öµå

Radiation; Cisplatinum; Rat brain

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS